Clough Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,700
| Closed | -$936K | – | 184 |
|
|
2022
Q4 | $936K | Buy |
+1,700
| New | +$936K | 0.09% | 130 |
|
|
2022
Q2 | – | Sell |
-9,167
| Closed | -$5.41M | – | 119 |
|
|
2022
Q1 | $5.41M | Sell |
9,167
-6,450
| -41% | -$3.81M | 0.41% | 62 |
|
|
2021
Q4 | $10.4M | Sell |
15,617
-17,580
| -53% | -$11.7M | 0.7% | 45 |
|
|
2021
Q3 | $19M | Sell |
33,197
-8,890
| -21% | -$5.08M | 1.15% | 34 |
|
|
2021
Q2 | $21.2M | Sell |
42,087
-5,455
| -11% | -$2.75M | 1.15% | 30 |
|
|
2021
Q1 | $21.7M | Sell |
47,542
-8,610
| -15% | -$3.93M | 0.97% | 32 |
|
|
2020
Q4 | $26.2M | Buy |
56,152
+13,679
| +32% | +$6.37M | 1.86% | 15 |
|
|
2020
Q3 | $18.8M | Buy |
42,473
+5,090
| +14% | +$2.25M | 1.35% | 24 |
|
|
2020
Q2 | $13.5M | Buy |
37,383
+7,325
| +24% | +$2.65M | 1.33% | 23 |
|
|
2020
Q1 | $8.52M | Sell |
30,058
-18,760
| -38% | -$5.32M | 0.85% | 34 |
|
|
2019
Q4 | $15.9M | Sell |
48,818
-8,530
| -15% | -$2.77M | 1.35% | 26 |
|
|
2019
Q3 | $16.7M | Buy |
57,348
+21,158
| +58% | +$6.16M | 1.38% | 22 |
|
|
2019
Q2 | $10.6M | Buy |
+36,190
| New | +$10.6M | 1.04% | 35 |
|